The most common pattern of SSTR2A staining was predominantly negative in glioblastomas (97%) and IDH-wildtype astrocytomas (86%) but also in the majority of IDH-mutant astrocytomas (65%). This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).